
神经药理学报››2016,Vol. 6››Issue (5): 14-21.DOI:10.3969/j.issn.2095-1396.2016.05.002
• 研究论文 •下一篇
汪林芳,黄术兵,徐一达,崔春,申延琴
出版日期:2016-10-26发布日期:2017-01-03通讯作者:申延琴,教授,硕士研究生导师;研究方向:神经退行性疾病;Tel&Fax:+86-510-85197596;E-mail:shenyanqin@jiangnan.edu.cn作者简介:汪林芳,女,硕士研究生;研究方向:神经退行性疾病;E-mail:18226622733@163.com 黄术兵,男,硕士研究生;研究方向:神经退行性疾病;E-mail:joaisheng@163.com基金资助:
国家自然科学基金项目(No.81650007)
WANG Lin-fang,HUANG Shu-bing,XU Yi-da,CUI Chun,SHEN Yan-qin
Online:2016-10-26Published:2017-01-03Contact:申延琴,教授,硕士研究生导师;研究方向:神经退行性疾病;Tel&Fax:+86-510-85197596;E-mail:shenyanqin@jiangnan.edu.cnAbout author:汪林芳,女,硕士研究生;研究方向:神经退行性疾病;E-mail:18226622733@163.com 黄术兵,男,硕士研究生;研究方向:神经退行性疾病;E-mail:joaisheng@163.comSupported by:
国家自然科学基金项目(No.81650007)
摘要:目的:研究马钱苷对神经毒素1- 甲基-4- 苯基-1,2,3,6- 四氢吡啶(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,MPTP)诱导的PC12 细胞自噬的影响。方法:MPTP 作用于PC12 细胞,观察MPTP 在不同时间和不同浓度对PC12 细胞中自噬相关因子微管相关蛋白1 轻链3-β(microtubule-associated protein1light chain 3-β,LC3B)的表达影响,并以此为基础探索马钱苷对MPTP 诱导的细胞自噬的影响和其潜在的作用通路。结果:PC12 细胞经MPTP 处理12 h 后,LC3B 的表达到达最高水平,且MPTP 在100 μg·mL-1 浓度下作用最强,而马钱苷在200 μg·mL-1 的浓度时降低MPTP 诱导的LC3B 高表达,在400 μg·mL-1 的浓度时降低了溶酶体膜相关蛋白2(lysosome associated membrane protein 2,LAMP-2)溶酶体标记蛋白的表达。结论:MPTP 在100 μg·mL-1 浓度下作用12 h,PC12 细胞内自噬蛋白的表达增加。马钱苷可降低MPTP 诱导的PC12 细胞内自噬体水平,并可能通过增强溶酶体对自噬体的消化实现的。
汪林芳,黄术兵,徐一达,崔春,申延琴.马钱苷对MPTP 诱导的PC12 细胞自噬的作用研究[J]. 神经药理学报, 2016, 6(5): 14-21.
WANG Lin-fang,HUANG Shu-bing,XU Yi-da,CUI Chun,SHEN Yan-qin.Effects of Loganin on MPTP-Induced Autophagy in PC12 Cells[J]. Acta Neuropharmacologica, 2016, 6(5): 14-21.
| 1. Syed F Ali, Zbigniew K Binienda, Syed Z Imam. Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in parkin dysfunction [J]. Int J Environ Res Public Health, 2011, 8(12): 4702-4713. 2. Min Kong, Ba Mao-wen, Ren Chao, et al. An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease [J]. Oncotarget, 2017, 8: 57316-57326. 3. Jerzy Leszek, George E Barreto, Kazimierz Gasiorowski, et al. Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system [J]. CNS Neurol Disord Drug Targets, 2016, 15(3): 329-336. 4. Mitesh Lotia, Joseph Jankovic. New and emerging medical therapies in Parkinson's disease [J]. Expert Opin Pharmacother, 2016, 17(7): 895-909. 5. Wang Xin, Timothy Huang, Bu Guo-jun, et al. Dysregulation of protein trafficking in neurodegeneration [J]. Mol Neurodegener, 2014, 9: 31. 6. Ana Maria Sanchez-Perez, Berta Claramonte-Clausell, Juan Vicente Sanchez-Andres, et al. Parkinson's disease and autophagy [J]. Parkinsons Dis, 2012, 2012: 429524. 7. Wang Zi-ying, Liu Jing-yi, Yang Chuan-bin, et al. Neuroprotective natural products for the treatment of Parkinson's disease by targeting the autophagy-lysosome pathway: a systematic review [J]. Phytother Res, 2017, doi: 10.1002/ptr.5834. 8. Rebecca Banerjee, M Flint Beal, Bobby Thomas. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications [J]. Trends Neurosci, 2010, 33(12): 541-549. 9. Brian Spencer, Rewati Potkar, Margarita Trejo, et al. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases [J]. J Neurosci, 2009, 29(43): 13578-13588. 10. Md Ataur Rahman, Hyewhon Rhim. Therapeutic implication of autophagy in neurodegenerative diseases [J]. BMB Rep, 2017, 50(7): 345-354 . 11. Orit Bar-Am, Tamar Amit, Moussa B H Youdim. Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro [J]. J Neurochem, 2007, 103(2): 500-508. 12. Zheng Hai-lin, Shunit Gal, Lev M Weiner, et al. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition [J]. J Neurochem, 2005, 95(1): 68-78. 13. Muller-Rebstein S, Trenkwalder C, Oertel W H, et al. Pharmacotherapy of Parkinson's disease : aspects of drug safety [J]. Nervenarzt, 2017, DOI: 10.1007/s00115-017-0345-8. 14. Hemant Kumar, Sandeep Vasant More, Han Sang-don, et al. Promising therapeutics with natural bioactive compounds for improving learning and memory--a review of randomized trials [J]. Molecules, 2012, 17(9): 10503-10539. 15. Yang Jin-song, Wu Xiao-hong, Yu Hao-gang, et al. Tangeretin inhibits neurodegeneration and attenuates inflammatory responses and behavioural deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease dementia in rats [J]. Inflammopharmacology, 2017, 25(4): 471-484. 16. Ki Yong Lee, Sang Hyun Sung, Seung Hyun Kim, et al. Cognitive-enhancing activity of loganin isolated from Cornus officinalis in scopolamine-induced amnesic mice [J]. Arch Pharm Res, 2009, 32(5): 677-683. 17. Seung-Hwan Kwon, Ji-Ah Kim, Sa-ik Hong, et al. Loganin protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells [J]. Neurochem Int, 2011, 58(4): 533-541. 18. Hyeri Kim, Kumju Youn, Mok-Ryeon Ahn, et al. Neuroprotective effect of loganin against Abeta25-35-induced injury via the NF-kappaB-dependent signaling pathway in PC12 cells [J]. Food Funct, 2015, 6(4): 1108-1116. 19. Yao Li, Peng Shi-xiao, Xu Yi-da, et al. Unexpected neuroprotective effects of loganin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity and cell death in zebrafish [J]. J Cell Biochem, 2017, 118(3): 615-628. 20. Carlos Fonck, Michel Baudry. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation [J]. Brain Res, 2001, 905(1-2): 199-206. 21. Daniel J Klionsky. Autophagy: from phenomenology to molecular understanding in less than a decade [J]. Nat Rev Mol Cell Biol, 2007, 8(11): 931-937. 22. Zou Jing, Chen Zhao-yu, Wei Xiao-bo, et al. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units [J]. Cell Death Dis, 2017, 8(6): e2854. 23. Zhang Sheng, Gui Xue-hong, Huang Li-ping, et al. Neuroprotective effects of beta-asarone against 6-hydroxy dopamine-induced parkinsonism via JNK/Bcl-2/Beclin-1 pathway [J]. Mol Neurobiol, 2016, 53(1): 83-94. 24. Yoshinobu Ichimura, Taichi Kumanomidou, Sou Yu-shin, et al. Structural basis for sorting mechanism of p62 in selective autophagy [J]. J Biol Chem, 2008, 283(33): 22847-22857. 25. Terje Johansen, Trond Lamark. Selective autophagy mediated by autophagic adapter proteins [J]. Autophagy, 2011, 7(3): 279-296. 26. Geir Bjorkoy, Trond Lamark, Andreas Brech, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death [J]. J Cell Biol, 2005, 171(4): 603-614. 27. Adolfo Garcia Erustes, Fernanda Yakel Stefani, Juliana Yoshie Terashima, et al. Overexpression of alpha-synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis [J]. J Neurosci Res, 2017. 28. Joungmok Kim, Mondira Kundu, Benoit Viollet, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 [J]. Nat Cell Biol, 2011, 13(2): 132-141. 29. Shen Yu-fei, Tang Yu, Zhang Xiao-jie, et al. Adaptive changes in autophagy after UPS impairment in Parkinson's disease [J]. Acta Pharmacol Sin, 2013, 34(5): 667-673. 30. Ana Maria Cuervo, J Fred Dice. A receptor for the selective uptake and degradation of proteins by lysosomes [J]. Science, 1996, 273(5274): 501-503. 31. Pang Shu-chao, Chen Dong-feng, Zhang Ai-mei, et al. Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease [J]. Neurosci Lett, 2012, 526(1): 63-67. |
| [1] | 李家劼, 刘金星, 周泽, 王亚平, 廖加抱, 罗成, 晏和国, 李洪梅, 李钦, 温伟波.病证结合2 型糖尿病湿热证动物模型的研究进展[J]. 神经药理学报, 2025, 15(3): 38-. |
| [2] | 陈晓阳, 王子祎, 谢亚昊, 靳琪, 刘思宁, 安佳怡, 刘亚萌, 强孟泽, 李家赓, 陈茁茁, 张元元, 于嘉琛, 杨志强.基于网络药理学和分子对接探讨牛磺酸治疗年龄相关性黄斑病变的机制[J]. 神经药理学报, 2024, 14(6): 1-. |
| [3] | 曹欣然, 樊建春, 王霞, 刘训涛, 张斌.CAV1 和CAV2 在头颈部鳞状细胞癌组织中的表达及其对生存、免疫的影响[J]. 神经药理学报, 2024, 14(4): 9-. |
| [4] | 付雨桐, 李慧敏, 董心怡, 杜世璇, 娄蕾, 崔晋峰, 王娟, 张庆, 苏凌瑞, 李月红.食管胃交界腺癌和远端胃腺癌中 HER2、RKIP 及ERK 表达的对比研究[J]. 神经药理学报, 2024, 14(2): 38-. |
| [5] | 孙晓静, 孟宪勇, 余会娇, 董晓华.TRIM32 与相关神经系统疾病的研究进展[J]. 神经药理学报, 2024, 14(2): 47-. |
| [6] | 陈莹, 尤继文, 林艳, 陈云香.保妇康栓联合重组人干扰素α-2b 治疗高危HPV感染的疗效和安全性观察[J]. 神经药理学报, 2024, 14(1): 18-. |
| [7] | 王鹏, 薛茜.河北张家口地区急性脑梗死患者CYP2C19基因多态性分析[J]. 神经药理学报, 2024, 14(1): 23-. |
| [8] | 张晋源, 梁花敏, 马薇.鼠神经生长因子联合rt-PA 治疗急性脑梗死的疗效及对血清ET-1、TXA2 水平的影响[J]. 神经药理学报, 2023, 13(6): 1-. |
| [9] | 朱静怡, 樊建春, 禹爱梅.普罗布考在保护神经系统中的研究现状[J]. 神经药理学报, 2023, 13(6): 50-. |
| [10] | 易妍, 商亚珍.BI-D1870对N2a细胞毒作用[J]. 神经药理学报, 2023, 13(3): 1-. |
| [11] | 于民权, 徐祥清, 赵松, 邱印利, 赵义.一种新型抗精神病药物—哌马色林的体内药效评价[J]. 神经药理学报, 2023, 13(3): 21-. |
| [12] | 高静, 吕建东.中药干预对子痫前期患者血镉及11β-HSD2异常表达的影响[J]. 神经药理学报, 2023, 13(3): 39-. |
| [13] | 高静, 张帅.妊娠高血压疾病发生发展潜在生物信息学机制初探[J]. 神经药理学报, 2023, 13(2): 24-. |
| [14] | 赵慧巧, 卢年华, 苏雅迪, 靳展洪叶, 付羽佳, 李仲平.基于“肠道菌群调控β-防御素2”探究败酱草对IBD肠纤维化大鼠的作用机制[J]. 神经药理学报, 2023, 13(1): 8-. |
| [15] | 赵朋涛, 闫聚瀚, 闫晓冬, 等.七叶皂苷钠对肾缺血再灌注的保护作用及机制[J]. 神经药理学报, 2022, 12(5): 17-. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||